V-Wave Ltd.
V-Wave’s Interatrial Shunt Receives FDA Breakthrough Device Designation for Heart Failure
The study is enrolling advanced HF patients with preserved or reduced left ventricular ejection fraction who remain symptomatic despite the use of guideline directed medical and device therapies.
